| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 254,757 | 212,540 | 172,320 | 202,025 | | Cost of Revenue | 163,207 | 138,539 | 142,487 | 163,613 | | | Gross Profit | 91,550 | 74,001 | 29,833 | 38,412 | | | Operating Expenses | | Research Development | 34,846 | 35,633 | 35,744 | 38,617 | | Selling General and Administrative | 32,576 | 26,317 | (749,952) | 753,821 | | Non Recurring |
-
|
-
| 800,563 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 24,128 | 12,051 | (56,522) | (754,026) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 212 | 2,217 | 11,733 | 6,316 | | Earnings Before Interest And Taxes | 24,340 | 14,268 | (44,789) | (747,710) | | Interest Expense | 6,260 | 6,414 | 2,400 | 2,501 | | Income Before Tax | 18,080 | 7,854 | (47,189) | (750,211) | | Income Tax Expense | 3,501 | 3,070 | 2,190 | 63,132 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 14,579 | 4,784 | (49,379) | (813,343) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,579 | 4,784 | (49,379) | (813,343) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,579 | $4,784 | ($49,379) | ($813,343) |
|
0.22% Nasdaq 
Income Statement
